$TPB: can Turning Point Brands be the third player in nicotine pouches? | Saberpoint Capital
Sabrepoint’s thesis is that TPB can become a durable third player in a nicotine-pouch market currently worth about $6.5 billion and growing roughly 22%. George Baxter argues the company combines established distribution, legal/regulatory competence and two credible brands—FRE and the Tucker Carlson-backed ALP—while most venture-funded challengers lack the capital or field salesforce to survive. His analogy is “Dr Pepper to Coca-Cola and Pepsi,” not displacing Zyn or Velo but maintaining roughly 5%-6% share, with a possible 5%-10% niche.
Nicotine pouches retain tobacco’s attractive economics while removing many of smoking’s practical and social constraints. They are cheap to manufacture, high-margin, addictive and usable on planes, in offices, elevators and movie theaters without the stigma of smoking. Baxter believes habitual users eventually associate one formulation with relief—nicotine withdrawal feels “just like hunger”—although Andrew Walker pushes back that flavors may make the category behave more like tea or energy drinks.
The American convenience-store channel may turn brand loyalty and shelf scarcity into stronger moats than European experience suggests. Roughly one-third of Swedish pouch sales occur online versus only about 4% in the U.S.; Americans tend to buy cans during daily convenience-store trips rather than committing to a $70-$80 online order. Retailers also prefer fewer, faster-selling brands, while TPB’s salesforce is expanding from roughly 260 to 320 representatives and can service independents that smaller competitors reach only through distributors.
Regulation is simultaneously weakening speculative pouch startups and reopening competition for the tobacco majors. The new PMTA pathway lets companies such as BAT and Philip Morris pursue flavors, strengths and formulations without acquiring every innovative startup, undermining the venture-backed strategy of winning shelf space and selling out to Big Tobacco. TPB’s edge is not immunity from that competition; it is that retailers asking “Will this company last?” can see an existing cash-generative business, legal/regulatory capability and national distribution behind it.
Near-term earnings are being suppressed by a deliberate—but not yet proven—investment year. Second-quarter revenue rose from about $116 million to $140 million, while spending accelerated on PMTA work, slotting fees, salespeople and the TKO/UFC partnership; Walker highlights concern over an estimated $20 million annual TKO commitment. Baxter expects store-launch fees to annualize downward over coming quarters and domestic production eventually to raise gross margin by roughly 15%, but concedes both timing and marketing ROI remain uncertain.
ALP is the portfolio’s breakout asset, while FRE remains the expensive brand-building experiment. Walker says the products themselves are effectively identical, yet ALP’s association with Tucker Carlson and a broader “rebellious” identity has produced dramatically better traction than FRE’s less coherent advertising. Walker’s key risk is celebrity leverage: Tucker owns half the venture and could demand better economics later; Baxter therefore expects TPB to pursue something like a 50%-to-70% increase rather than attempt an unaffordable full buyout.
At roughly $60 per share, Baxter believes investors are paying little for the pouch optionality—but he openly flags his own confirmation bias. He values Zig-Zag, Stoker’s and the other legacy assets at roughly $35-$45 per share, leaving about $15 per share, or approximately $300 million, for FRE and ALP. His upside case assumes a 10%-30% category CAGR through 2030 and ALP eventually reaching about 10% share, but he closes by admitting this is “the best idea of my career” and that domestic manufacturing already unfolded differently from his expectations.
1. TPB has turned a mixed legacy portfolio into a pouch platform
Baxter first encountered Turning Point Brands through its legacy collection: a U.S. license to distribute Zig-Zag rolling papers, Stoker’s moist snuff and older products such as chewing candy and Beech Nuts, plus an online vape distributor later damaged by the 2019 “Vapegate” crisis. Baxter attributed that incident to homemade marijuana pods containing vitamin E acetate. Zig-Zag remains high-margin but inventory-heavy; one shipment can supply a retailer for six months, producing long destocking cycles that obscure underlying demand.
Stoker’s has continued growing despite declines in the moist-snuff and chewing-candy markets, while the troubled vape operation was eventually placed into a joint venture in which TPB retained 49%. The strategic reset came with FRE’s nationwide launch in early 2024 and the subsequent 50/50 ALP venture with Tucker Carlson.
Baxter says pouches went from virtually nothing to approximately 48% of TPB’s recent revenue. Against that shift, the legacy businesses matter less as growth engines than as the cash flow and sales infrastructure supporting entry into a rapidly expanding category.
2. Pouches preserve nicotine economics while making consumption almost frictionless
Baxter’s historical framing is deliberately stark: cigarettes were socially destructive but perhaps “the most successful product in history.” He says a Philip Morris investment made 98 years ago would have delivered an average annual return of roughly 16.5% because addiction, low manufacturing cost and unusually durable brand loyalty created extraordinary economics.
The pouch category, barely established before COVID-19, is now about $6.5 billion. Recent Nielsen growth is approximately 22%, versus a five-year average around 37%-38%, giving TPB a high-margin growth market after years of operating legacy products facing secular decline.
Baxter’s strongest demand-side point is convenience. A smoker or vaper cannot consume on a four-hour flight, in an elevator, at a movie or inside an office; a pouch user can consume almost invisibly throughout the day. That allows nicotine to occupy occasions where cigarettes, alcohol and cannabis are socially or practically impossible.
The health-harm reduction argument matters, but Walker sees discretion as equally powerful: “Even if I make a wrong choice, no one will know.” Pouches therefore benefit both from younger consumers rejecting smoking and from existing nicotine users wanting a format compatible with modern indoor life.
3. Brand loyalty remains the central disagreement
Walker challenges the cigarette analogy because pouch users may rotate orange, mango, wintergreen and mint like tea or energy-drink flavors. His question is whether a category with easy experimentation will ever produce the near-absolute loyalty seen when a Marlboro smoker refuses a Winston.
Baxter concedes that casual and early-stage users experiment, but argues habitual users eventually connect relief with a particular release profile and formulation. After trying essentially every product, he repeatedly returns to ALP and FRE Wintergreen or Mint because they deliver the familiar “sense of relief and satisfaction”; addiction, in his formulation, feels “just like hunger.”
Baxter’s own friends complicate the “last pack” analogy. Many young pouch users do not tell themselves, “This is the last nicotine pouch”; they think, “This is who I am.” That could support long customer lives, but it also leaves unresolved whether identity attaches to nicotine pouches broadly or to one brand specifically.
4. U.S. distribution could produce a durable third winner
Only about 4% of U.S. pouch sales occur online, Baxter says, versus roughly one-third in Sweden. Free shipping commonly requires a $70-$80 order—about 15 cans—while many consumers prefer grabbing cans during a coffee or convenience-store trip, either from habit or because they resist stockpiling an addictive product.
Walker argues convenience stores already support numerous energy-drink, soda and flavor SKUs, so shelf space need not collapse to two pouch brands. Baxter’s rebuttal is that nicotine purchases are more purposeful: excessive choice slows customers and confuses clerks, while buyers report faster sales velocity from tighter assortments.
Zyn and Velo are major incumbents, but retailers do not want those suppliers dictating every promotion and rebate. TPB can schedule discounts more flexibly, serve price-sensitive customers and give stores bargaining leverage—creating room for a smaller “Dr Pepper” with perhaps 5%-10% share.
Survival capacity separates TPB from venture-backed brands such as Sesh, Lucy and Juice Head. Retail buyers repeatedly ask, “Will this company last?” TPB can answer with existing cash flow, regulatory experience and a field salesforce growing from roughly 260 to 320 representatives, versus startup teams often numbering only around ten.
5. PMTA reform helps Big Tobacco but may strand smaller challengers
The earlier regime imposed different filing deadlines on tobacco-derived and synthetic nicotine—roughly 2020 and 2022—and made every formulation or flavor change painfully slow. Baxter says this produced a vape market in which 70%-80% of products became illegal Chinese flavored disposables while compliant incumbents struggled to innovate.
Under the new framework announced in May, Baxter says companies can submit fresh scientific packages and pursue marketing authorization for new products. BAT has already started selling flavored e-cigarette pods, while Zyn plans a 1.5-milligram product; large companies no longer need to acquire a startup simply to obtain innovation.
That change damages the venture-capital playbook of paying slotting fees, winning a large chain and selling the brand to Big Tobacco. Without a credible acquisition exit, smaller companies may exhaust their funding, whereas TPB can finance continued participation from the broader business.
Product competition is nevertheless intensifying. Baxter considers Velo Plus “much better than Zyn” and says its share rose toward 20%, while Zyn fell from roughly 78% early last year to about 54%. Zyn Ultra appears largely to be cannibalizing original Zyn, with the combined franchise growing only about 2% year over year.
6. Today’s margin pressure contains identifiable—but delayed—relief
Walker frames the financial tension clearly: second-quarter revenue increased from roughly $116 million to $140 million, yet profits declined as management funded FRE, ALP, PMTA submissions, slotting payments and the TKO partnership. The concern is that investors are underwriting future economics while absorbing a potentially fixed annual TKO cost near $20 million.
Domestic manufacturing was supposed to offset part of that burden but has not begun. Baxter says current cost is around $1.40 per can; Indian manufacturing would cost about $1 per can plus $0.20-$0.25 of air freight and a 16% tariff. Moisture makes a six-week ocean voyage impractical. U.S. production could reduce cost toward $0.65 and raise gross margin by about 15%.
Equipment is installed in Louisville and one line is operational, but switching facilities before marketing authorization could restart the PMTA queue. Baxter views approval and the supporting supplemental submission as timing questions, not fatal obstacles, while admitting production might begin soon or slip toward next year.
Slotting economics should also normalize. A launch can cost roughly $1,000-$2,000 per store, but after a year successful products may shift toward about $0.50 per can—approximately $260 annually per store for FRE and $500 for ALP at cited velocities. Privately owned independent stores do not charge slotting fees, further favoring TPB’s direct network. Baxter expects improvement from the third and fourth quarters, with broader annualization by next year’s first or second quarter.
7. ALP has the brand identity that FRE is still trying to manufacture
FRE’s core problem was awareness, so TPB spent aggressively on UFC and other partnerships. Baxter accepts that the campaigns raise recognition but questions their coherence: playful commercials do not fully express the intensity implied by UFC, drifting, boxing, bull riding and strongman sponsorships. The desired message is closer to “Own Your Power.”
ALP succeeded by linking Tucker Carlson’s independent, conservative and rebellious persona directly to the brand, then broadening that identity through figures such as Conor McGregor. Baxter’s distinction is that ALP associates personalities with a consistent character; FRE has bought substantial exposure without yet defining what “FRE” means.
Walker says there is “absolutely no difference” between the underlying ALP and FRE pouches beyond packaging. If that comparison is right, ALP’s growth is evidence of branding power, but also suggests FRE’s marketing can improve quickly if TPB adopts ALP’s playbook and eliminates less productive spending.
Walker preserves the central governance risk: celebrity economics often become more favorable to the celebrity at renewal. Tucker owns half the venture and could threaten to promote another supplier. Baxter considers a full acquisition financially unrealistic and predicts TPB may instead raise ownership from 50% to roughly 70%, leaving Tucker invested but reducing his control.
Baxter estimates ALP generated approximately $280 million of revenue last quarter, up 300% year over year. At his suggested 10-times-revenue valuation, ALP would be worth about $2 billion and Tucker’s half about $1 billion, making a full buyout unaffordable and supporting his prediction of a partial purchase.
8. Valuation depends on execution, and the bull explicitly admits his bias
At approximately $60 per share and a $1.2 billion market capitalization, Walker arrives at enterprise value near $1.25 billion after correcting for cash and debt. Baxter values Zig-Zag, Stoker’s and the remaining established businesses at roughly $35-$45 per share, implying only about $15 per share, or $300 million, for FRE and ALP.
Management uncertainty increased when the CEO abruptly stepped down for personal reasons and chairman David Glazek, a Standard General veteran, took the role. Baxter sees Glazek as deeply informed and newly accountable: “He will not be able to avoid any mistakes going forward.” Yet low insider ownership, recent ATM usage and aggressive spending keep the alignment question open.
Baxter estimates directors collectively own around 5%, former CEO Larry Wexler about 2.5% and Glazek roughly 0.5%, while 11 activist holders together exceed 10%. That shareholder pressure, plus Glazek surrendering a comparatively lower-risk chairman position, should create urgency to show operating improvement.
The upside case assumes pouch-market growth of 10%-30% annually through 2030 and ALP eventually reaching about 10% share. In the stores where the products are present, George cites current shares of roughly 11% for ALP and 6% for FRE; together, ALP and FRE already represent more than half of online pouch sales, mostly through ALP. Baxter nevertheless closes with the essential warning: he publicly called TPB “the best idea of my career,” acknowledges confirmation and consistency bias, and admits, “Things unfolded in a way I hadn’t anticipated or expected.”